Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 5:15:1475975.
doi: 10.3389/fphar.2024.1475975. eCollection 2024.

Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation

Affiliations
Review

Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation

Yang Wang et al. Front Pharmacol. .

Abstract

Heart failure (HF) is a clinical condition caused by abnormalities in the heart's structure or function, primarily manifested as diminished ability of the heart to pump blood, which leads to compensatory activation of neurohormones and increased left ventricular filling pressure. HF is one of the fastest-growing cardiovascular diseases globally in terms of incidence and mortality, negatively impacting patients' quality of life and imposing significant medical and economic burdens. Despite advancements in the treatment of HF, hospitalization and mortality remain rates high. In China, Chinese herbal medicine (CHM) has historically played a prominent role in addressing HF, with significant proven efficacy. MicroRNA (miRNA) exerts a pivotal regulatory influence on the maintenance of regular cardiac activity and the progression of HF. MiRNAs, a category of single-stranded RNA molecules, are characterized by their inability to code for proteins. They regulate gene expression by binding to the 3'-untranslated region (3'-UTR) of target mRNAs, thereby influencing the onset and progression of various diseases. Abnormal expression of specific miRNAs is closely associated with HF pathological processes, such as cardiomyocyte apoptosis, myocardial fibrosis, and cardiac hypertrophy. This abnormal expression can influence the pathological progression of HF through the regulation of miRNA expression. This article reviews the regulatory role of miRNAs in HF pathology discusses how CHM compounds and their active ingredients can ameliorate HF pathology through the regulation of miRNA expression. In conclusion, miRNAs represent promising therapeutic targets for HF, and CHM provides a novel strategy for treatment through the regulation of miRNA expression. Future studies must delve deeper into the precise mechanisms by which CHM modulates miRNAs and fully explore its potential for clinical application in HF treatment.

Keywords: Chinese herbal medicine; apoptosis; cardiac fibrosis; cardiac hypertrophy; heart failure; microRNA; therapeutic strategies.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer DL declared a shared affiliation with the author ZC to the handling editor at the time of review.

Figures

FIGURE 1
FIGURE 1
The biogenesis and mechanism of action of microRNAs.
FIGURE 2
FIGURE 2
Summary of the impact of microRNAs on heart failure.

Similar articles

Cited by

References

    1. Al-Mohammad A., Mant J. (2011). The diagnosis and management of chronic heart failure: review following the publication of the NICE guidelines. Heart 97 (5), 411–416. 10.1136/hrt.2010.214999 - DOI - PubMed
    1. Al-Mohammad A., Mant J., Laramee P., Swain S. Chronic Heart Failure Guideline Development Group (2010). Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance. Bmj 341, c4130. 10.1136/bmj.c4130 - DOI - PubMed
    1. Amgalan D., Kitsis R. N. (2019). A mouse model for the most common form of heart failure. Nature 568 (7752), 324–325. 10.1038/d41586-019-00983-4 - DOI - PMC - PubMed
    1. Bauersachs R., Zeymer U., Brière J. B., Marre C., Bowrin K., Huelsebeck M. (2019). Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc. Ther. 2019, 8295054. 10.1155/2019/8295054 - DOI - PMC - PubMed
    1. Bo R., Zheng S., Xing J., Luo L., Niu Y., Huang Y., et al. (2016). The immunological activity of Lycium barbarum polysaccharides liposome in vitro and adjuvanticity against PCV2 in vivo . Int. J. Biol. Macromol. 85, 294–301. 10.1016/j.ijbiomac.2015.12.089 - DOI - PubMed

LinkOut - more resources